APBI 2016

• We know what we know – and that comes from the past  we have to cope with that • Comparative data on toxicity and QoL of RT vs adjuvant hormonal treatment are lacking • Our “feelings” on risks and treatment benefits probably need to be adapted • What’s new tomorrow will be challenged again ~ possibly outdated after tomorrow Interaction between local & systemic treatment